Titre:
  • Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study.
Auteur:Demols, Anne; Peeters, Marc; Polus, Marc; Marechal, Raphaël; Gay, France; Monsaert, Els; Hendlisz, Alain; Van Laethem, Jean-Luc
Informations sur la publication:British Journal of Cancer, 94, 4, page (481-485)
Statut de publication:Publié, 2006-02
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Advanced and metastatic pancreatic cancer
Gemcitabine plus oxaliplatin
Second line chemotherapy
MeSH keywords:Adenocarcinoma -- drug therapy -- pathology
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- therapeutic use
Deoxycytidine -- administration & dosage -- analogs & derivatives
Disease Progression
Drug Resistance, Neoplasm
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Organoplatinum Compounds -- administration & dosage
Pancreatic Neoplasms -- drug therapy -- pathology
Survival Analysis
Treatment Outcome
Note générale:Clinical Trial, Phase II
Journal Article
Multicenter Study
Langue:Anglais
Identificateurs:urn:issn:0007-0920
info:doi/10.1038/sj.bjc.6602966
info:pii/6602966
info:scp/33344468699
info:pmid/16434988
PMC2361170